ALKM - Alkame Plans to Begin Process for Uplisting to OTCQB
April 21 2022 - 11:55AM
InvestorsHub NewsWire
LAS VEGAS, NV -- April 21, 2022 -- InvestorsHub NewsWire --
Alkame Holdings, Inc. (OTC
PINK: ALKM), is pleased to announce that it will begin the
process for moving off the OTC Pink Sheets and uplisting to the
OTCQB. The Company will be hiring an auditing firm to assist with
the uplisting.
The Company believes that the move to the OTCQB will provide
enhanced investor benefits including higher reporting standards,
greater access to analyst coverage and news services, and more
comprehensive compliance requirements. The OTCQB is considered by
the Securities and Exchange Commission (SEC) as an "established
public market" for determining the public market price when
registering securities for resale with the SEC. The OTC Pink is not
considered as such, and most broker dealers will not trade or
recommend OTC Pink stocks. Because the OTCQB dramatically increases
transparency, reporting standards, management certification and
compliance requirements, most broker dealers trade stocks on the
OTCQB. Historically, companies that have made the move up to the
OTCQB® tier have experienced increased investor awareness, greater
liquidity and visibility of their common stock.
"Uplisting to the OTCQB will assist our company in providing
greater shareholder value. It will allow us to achieve greater
market visibility along with increased trading liquidity within the
investment community. We look forward to showcasing our company to
a larger audience of domestic and international investors,” Stated
Robert Eakle, Alkame CEO. Eakle continued “Uplisting to OTCQB is
the first of several exciting advancements, as we continue to make
our way to NASDAQ."
For More Information See: OTCQB
Eligibility Requirements
About OTC Markets
Group and the OTCQB® Venture
Market
OTC Markets Group Inc. operates financial markets for 11,000
U.S. and global securities. We organize these securities into three
markets based on the quality and timeliness of information a
company provides to investors: the OTCQX® Best Market, the OTCQB®
Venture Market, and the Pink® Open Market. We utilize the power of
technology to make markets more efficient, empowering a broad range
of companies to improve their investor experience - all without the
cost, complexity and resource drain common with an exchange
listing.
The OTCQB® Venture Market is for entrepreneurial and development
stage U.S. and international companies. To be eligible, companies
must be current in their reporting, have a minimum bid price of
$0.01, may not be in bankruptcy and must undergo an annual
verification and management certification process. These standards
provide a strong baseline of transparency to improve the
information and trading experience for investors.
https://www.otcmarkets.com
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a diversified publicly traded holding
company. The Company's wholly owned subsidiaries manufacture
products that utilize an enhanced water proprietary technology when
applicable to create products with several unique properties. The
organization is diligently building a strong foundation through the
launch and acquisition of appropriate business assets, and by
pursuing multiple applications by placement into several emerging
business sectors, such as consumer food and beverages products,
hemp products, household pet products, horticulture and agriculture
applications, hand sanitizers, and many other various water-based
treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains
forward-looking statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and
uncertainties. Among others, these risks include the expectation
that Alkame will achieve significant sales, the failure to meet
schedule or performance requirements of the Company's contracts,
the Company's liquidity position, the Company's ability to obtain
new contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any disease.
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Dec 2023 to Dec 2024